[ET Net News Agency, 17 July 2025] KEYMED BIO-B (02162) rose 10.5% to HK$55.25.
It hits an intra-day high of HK$55.3, hitting a 52-week high, and an intra-day low of
HK$50. The total shares traded was 3.48 million, with a value of HK$185.06m. The active
buy/sell ratio is 65:35, with net buying turnover of HK$54.04m. HUATAI FIN HLDGS HK
accounts for greatest net responsive buying turnover of HK$8.47m, with volume weighted
average price of HK$53.378. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive
selling turnover of HK$34.68m, with volume weighted average price of HK$53.203. The stock
has risen a combined 21.4% over the past 5 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 55.250 % Chg +10.50%
High 55.300 Low 50.000
Shares Tr 3.48m Turnover 185.06m
10-D SMA 47.645 %H.V 41.301
20-D SMA 47.222 VWAP 53.116
50-D SMA 45.001 RSI14 73.562
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 65:35, with net buying turnover
of HK$54.04m, rising a combined 21.4% over the past 5 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 55.25 +10.50
SINO BIOPHARM (01177) 6.67 +3.57
3SBIO (01530) 29.85 +6.80
EVEREST MED (01952) 72.15 -0.35
WUXI XDC (02268) 50.35 +3.18
ASCENTAGE-B (06855) 78.50 +6.30
SKB BIO-B (06990) 383.60 +7.93
ZAI LAB (09688) 29.30 +5.59
AKESO (09926) 139.20 +10.48
REMEGEN (09995) 69.15 +0.80
---------------------------------------------
(ed)